10x Genomics, Inc. TXG Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s change in other liabilities?
- 10x Genomics, Inc. (TXG) reported change in other liabilities of -$50K in Q1 2026.
- How has 10x Genomics, Inc.'s change in other liabilities changed year-over-year?
- 10x Genomics, Inc.'s change in other liabilities decreased by 113.9% year-over-year, from $360K to -$50K.
- What is the long-term trend for 10x Genomics, Inc.'s change in other liabilities?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s change in other liabilities has grown at a -27.1% compound annual growth rate (CAGR), from -$4.93M to $1.4M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.